NAV Stock Chart & Stats
C$0.01
--
Market closed
C$0.01
--
Day’s Range― - ―
52-Week Range<C$0.01 - C$0.01
Previous CloseN/A
VolumeN/A
Average Volume (3M)12.95K
Market Cap
C$285.35K
Enterprise ValueC$640.51K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.03
Next Earnings
Mar 08, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding57,069,542
10 Day Avg. Volume3,444
30 Day Avg. Volume12,948
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
NAVCO Pharmaceuticals Inc News
NAV FAQ
What was NAVCO Pharmaceuticals Inc’s price range in the past 12 months?
NAVCO Pharmaceuticals Inc lowest stock price was <C$0.01 and its highest was C$0.01 in the past 12 months.
What is NAVCO Pharmaceuticals Inc’s market cap?
NAVCO Pharmaceuticals Inc’s market cap is C$285.35K.
When is NAVCO Pharmaceuticals Inc’s upcoming earnings report date?
NAVCO Pharmaceuticals Inc’s upcoming earnings report date is Mar 08, 2027 which is in 244 days.
How were NAVCO Pharmaceuticals Inc’s earnings last quarter?
NAVCO Pharmaceuticals Inc released its earnings results on Jun 01, 2026. The company reported C$0 earnings per share for the quarter, the consensus estimate of N/A by C$0.
Is NAVCO Pharmaceuticals Inc overvalued?
According to Wall Street analysts NAVCO Pharmaceuticals Inc’s price is currently Overvalued.
Does NAVCO Pharmaceuticals Inc pay dividends?
NAVCO Pharmaceuticals Inc does not currently pay dividends.
What is NAVCO Pharmaceuticals Inc’s EPS estimate?
NAVCO Pharmaceuticals Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NAVCO Pharmaceuticals Inc have?
NAVCO Pharmaceuticals Inc has 57,069,542 shares outstanding.
What happened to NAVCO Pharmaceuticals Inc’s price movement after its last earnings report?
NAVCO Pharmaceuticals Inc reported an EPS of C$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of NAVCO Pharmaceuticals Inc?
Currently, no hedge funds are holding shares in TSE:NAV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
NAVCO Pharmaceuticals Inc
BMGB Capital Corp is a capital pool company.
Technical Analysis
Genix Pharmaceuticals
―
―
ZYUS Life Sciences
―
Lumiera Health Inc
―
LSL Pharma Group Inc
―